These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1424856)

  • 21. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
    Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
    Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
    Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
    Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease.
    Tandon MK
    Chest; 1993 Jan; 103(1):105-10. PubMed ID: 8380266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K; Koyama H; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):835-43. PubMed ID: 1385837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD.
    Bennett WD; Chapman WF; Mascarella JM
    Chest; 1993 Feb; 103(2):488-95. PubMed ID: 8432142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.
    Dorinsky PM; Reisner C; Ferguson GT; Menjoge SS; Serby CW; Witek TJ
    Chest; 1999 Apr; 115(4):966-71. PubMed ID: 10208193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis.
    van Schayck CP; Folgering H; Harbers H; Maas KL; van Weel C
    Thorax; 1991 May; 46(5):355-9. PubMed ID: 1829865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
    Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V; Ambery C
    Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.
    Thomas P; Pugsley JA; Stewart JH
    Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.
    Newnham DM; Dhillon DP; Winter JH; Jackson CM; Clark RA; Lipworth BJ
    Thorax; 1993 Nov; 48(11):1151-5. PubMed ID: 8296260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.